IMMX
IMMX
NASDAQ · Biotechnology

Immix Biopharma Inc

$12.50
-0.22 (-1.73%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -4.2% upside
Low Target $7.05
Average Target $11.98
High Target $14.20
Current Price $12.50
Current
$12.50
Target
$11.98
$7.05 $11.98 avg $14.20
Scenario Analysis
Bear Case
$7.05
-43.6%
Low target
Base Case
$11.98
-4.2%
Avg target
Bull Case
$14.20
+13.6%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$15.10
-17.2% from high
52-Week Low
$1.94
+544.3% from low
50-Day SMA
$9.43
+32.6% vs SMA
RSI (14)
67.2
Neutral
Target vs 52W High
$11.98
-20.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%